We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
145 hedge funds and large institutions have $643M invested in Arcturus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
5.44% more ownership
Funds ownership: 88.98% → 94.42% (+5.4%)
1% more funds holding
Funds holding: 144 → 145 (+1)
2% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 52
5% less capital invested
Capital invested by funds: $678M → $643M (-$34.5M)
13% less call options, than puts
Call options by funds: $6.3M | Put options by funds: $7.24M
Holders
145
Holders Change
+1
Holders Change %
+0.69%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
51
Reduced
52
Closed
20
Calls
$6.3M
Puts
$7.24M
Net Calls
-$934K
Net Calls Change
+$2.99M
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$9.74M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.83M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4.39M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.79M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.65M |
